- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
Norwegian Pharmaceuticals & Biotech Strong Balance Sheet Stocks
UPDATED May 24, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
13 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PCIB | kr1.65 | 1.2% | -10.3% | kr61.6m | n/a | PS20.6x | n/a | n/a | ||
LYTIX | kr6.00 | 7.1% | -39.7% | kr240.4m | kr13.00 | PS23.5x | S102.7% | n/a | ||
AZT | kr25.95 | 10.4% | -38.6% | kr1.3b | kr27.50 | PE75.2x | E48.5% | n/a | ||
NORD | kr41.00 | 0% | n/a | kr203.8m | n/a | PE2x | n/a | 0% | ||
NYKD | kr14.84 | 1.2% | -47.4% | kr4.8b | kr43.00 | PS41.5x | E-23.3% | n/a | ||
PHO | kr59.60 | -0.7% | 15.3% | kr1.6b | kr86.00 | PE335x | E91.9% | 0% | ||
ULTI | kr7.17 | -2.4% | -93.9% | kr246.7m | kr6.50 | PB1x | E28.5% | n/a | ||
TRMED | kr1.05 | 1.7% | n/a | kr246.1m | n/a | PB0.9x | n/a | n/a | ||
VISTN | kr22.40 | 1.8% | -0.4% | kr993.3m | n/a | PE17.6x | n/a | 4.5% | ||
ABS | kr10.20 | 2.0% | 10.9% | kr258.8m | kr10.00 | PS7.7x | E-6.0% | n/a | ||
BGBIO | kr0.13 | -4.3% | -65.8% | kr488.6m | n/a | PS1380.2x | E-19.9% | n/a | ||
EXTX | kr7.20 | 1.4% | -36.3% | kr231.0m | n/a | PS51812.5x | n/a | n/a | ||
NANOV | kr2.00 | -18.3% | -22.2% | kr231.8m | n/a | PB3.6x | n/a | n/a |
Page 1 of 1